Contents

27 June 2017
Vol 10, Issue 485

About The Cover

Cover image expansion

Online Cover This week features a Research Article that identifies a promising therapeutic for patients with colorectal cancer. The drug SSTC3 inhibited the growth of WNT-driven intestinal tumors with minimal toxicity because of differential abundance of its target, the kinase CK1α, in the tumor and the healthy epithelium. The image is hemotoxylin- and eosin-stained intestinal tissue from mice. [Image: Bin Li, Miller School of Medicine, University of Miami, Florida]